Olestra and the FDA [1]

New England Journal of Medicine

Volumn 335, Issue 9, 1996, Pages 668-670

  Kleinman, R E ^a   Schneeman, B ^a   Manning, W J ^a   Stampfer, M J ^a   Willett, W C ^a   Karstadt, M ^a   Jacobson, M F ^a   Blackburn, H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; CAROTENOID; FOOD ADDITIVE; SUCROSE POLYESTER; DRUG DERIVATIVE; EDIBLE OIL; FATTY ACID; SUCROSE; VITAMIN K GROUP; WARFARIN;

ANIMAL CELL; DIET SUPPLEMENTATION; DRUG APPROVAL; FOOD INTAKE; FOOD PROCESSING; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN CELL; LETTER; LIPID ABSORPTION; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; DRUG ANTAGONISM; DRUG CONTRAINDICATION; FOOD AND DRUG ADMINISTRATION; METABOLISM; NOTE; UNITED STATES;

DIETARY FATS, UNSATURATED; FATTY ACIDS; HUMANS; SUCROSE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VITAMIN K; WARFARIN; DRUG APPROVAL;

EID: 0029796477     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199608293350913     Document Type: Letter

References (0)